CANNAPHARMARX, INC. financial data

Symbol
CPMD on OTC
Location
Mountain View County
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 14 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 4.5% %
Quick Ratio 3.5% %
Debt-to-equity -153% %
Return On Equity 34% %
Return On Assets -65% %
Operating Margin -248% % 26%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 662,501,405 shares 0%
Common Stock, Shares, Outstanding 662,501,405 shares 0%
Entity Public Float $9,275,020 USD
Common Stock, Value, Issued $66,250 USD 0%
Weighted Average Number of Shares Outstanding, Basic 662,501,405 shares 0%
Weighted Average Number of Shares Outstanding, Diluted 662,501,405 shares 125%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $1,705,667 USD 405%
General and Administrative Expense $81,439 USD -38%
Operating Income (Loss) $4,226,588 USD -276%
Nonoperating Income (Expense) $542,165 USD -177%
Net Income (Loss) Attributable to Parent $7,322,704 USD -631%
Earnings Per Share, Basic -0.03 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $1,208 USD -44%
Accounts Receivable, after Allowance for Credit Loss, Current $14,145 USD
Inventory, Net $863,807 USD -29%
Assets, Current $1,470,755 USD -1.8%
Property, Plant and Equipment, Net $123,333 USD -20%
Operating Lease, Right-of-Use Asset $5,504,692 USD -0.13%
Assets $11,616,907 USD -0.55%
Accounts Payable, Current $5,612,709 USD -37%
Accrued Liabilities, Current $4,386,570 USD
Liabilities, Current $28,480,524 USD 27%
Liabilities $34,133,650 USD 21%
Accumulated Other Comprehensive Income (Loss), Net of Tax $173,530 USD 335%
Retained Earnings (Accumulated Deficit) $101,874,736 USD -0.68%
Stockholders' Equity Attributable to Parent $22,516,743 USD -36%
Liabilities and Equity $11,616,907 USD -0.55%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $601,381 USD -9.6%
Net Cash Provided by (Used in) Financing Activities $600,433 USD 7.2%
Net Cash Provided by (Used in) Investing Activities $0 USD
Common Stock, Shares Authorized 5,000,000,000 shares 0%
Common Stock, Shares, Issued 662,501,405 shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $948 USD -108%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $927 USD -87%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 USD
Depreciation $0 USD -100%
Payments to Acquire Property, Plant, and Equipment $0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $7,189,052 USD -647%
Property, Plant and Equipment, Gross $211,042 USD 3.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.17 pure
Deferred Tax Assets, Operating Loss Carryforwards $24,590,884 USD 3.1%
Preferred Stock, Shares Authorized 3,200,000 shares
Operating Lease, Payments $261,285 USD 29%
Additional Paid in Capital $81,379,443 USD 1.6%
Preferred Stock, Shares Outstanding 629,416 shares
Depreciation, Depletion and Amortization $0 USD
Deferred Tax Assets, Net of Valuation Allowance $24,978,343 USD 3.2%
Interest Expense $2,101,572 USD -15%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%